Detalles de la búsqueda
1.
Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial.
Lancet Oncol
; 17(10): 1396-1408, 2016 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-27569442
2.
Escalated-dose versus control-dose conformal radiotherapy for prostate cancer: long-term results from the MRC RT01 randomised controlled trial.
Lancet Oncol
; 15(4): 464-73, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24581940
3.
Celecoxib plus hormone therapy versus hormone therapy alone for hormone-sensitive prostate cancer: first results from the STAMPEDE multiarm, multistage, randomised controlled trial.
Lancet Oncol
; 13(5): 549-58, 2012 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-22452894
4.
An exact method for analysis following a two-stage phase II cancer clinical trial.
Stat Med
; 29(30): 3118-25, 2010 Dec 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-21170906
5.
Marginal structural models with dose-delay joint-exposure for assessing variations to chemotherapy intensity.
Stat Methods Med Res
; 28(9): 2787-2801, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29916309
6.
Quality of Life of Patients With Osteosarcoma in the European American Osteosarcoma Study-1 (EURAMOS-1): Development and Implementation of a Questionnaire Substudy.
JMIR Res Protoc
; 8(8): e14406, 2019 Sep 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-31573951
7.
Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort.
Eur J Cancer
; 109: 36-50, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30685685
8.
Comparison of HER-2 and hormone receptor expression in primary breast cancers and asynchronous paired metastases: impact on patient management.
Oncologist
; 13(8): 838-44, 2008 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-18650259
9.
Letrozole versus letrozole plus Lapatinib (GW572016) in hormone-sensitive, HER2-negative operable breast cancer: a double-blind, randomized, phase II study with biomarker evaluation (EGF109077-LAP107692/LETLOB).
Clin Breast Cancer
; 8(1): 97-100, 2008 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-18501066
10.
Middle turbinate preservation versus middle turbinate resection in endoscopic surgical treatment of nasal polyposis.
Acta Otolaryngol
; 128(9): 1019-26, 2008 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-19086309
11.
Two-years Postradiotherapy Biopsies: Lessons from MRC RT01 Trial.
Eur Urol
; 73(6): 968-976, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29307509
12.
Prognostic and predictive value of baseline and posttreatment molecular marker expression in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy.
Int J Radiat Oncol Biol Phys
; 68(5): 1455-61, 2007 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-17445998
13.
A Randomised Comparison Evaluating Changes in Bone Mineral Density in Advanced Prostate Cancer: Luteinising Hormone-releasing Hormone Agonists Versus Transdermal Oestradiol.
Eur Urol
; 69(6): 1016-25, 2016 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-26707868
14.
Final Report of the Intergroup Randomized Study of Combined Androgen-Deprivation Therapy Plus Radiotherapy Versus Androgen-Deprivation Therapy Alone in Locally Advanced Prostate Cancer.
J Clin Oncol
; 33(19): 2143-50, 2015 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-25691677
15.
Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial.
J Clin Oncol
; 33(20): 2279-87, 2015 Jul 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-26033801
16.
Preoperative chemotherapy plus lapatinib or trastuzumab or both in HER2-positive operable breast cancer (CHERLOB Trial).
Clin Breast Cancer
; 8(2): 192-4, 2008 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-18621618
17.
Flexible trial design in practice - stopping arms for lack-of-benefit and adding research arms mid-trial in STAMPEDE: a multi-arm multi-stage randomized controlled trial.
Trials
; 13: 168, 2012 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-22978443
18.
Neoadjuvant treatment with single-agent cetuximab followed by 5-FU, cetuximab, and pelvic radiotherapy: a phase II study in locally advanced rectal cancer.
Int J Radiat Oncol Biol Phys
; 73(2): 466-72, 2009 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-19004567
19.
Phase II, randomized trial of preoperative epirubicin-paclitaxel +/- gefitinib with biomarker evaluation in operable breast cancer.
Breast Cancer Res Treat
; 110(1): 127-34, 2008 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-17687648
20.
Helicobacter pylori infection and chronic immune thrombocytopenic purpura: long-term results of bacterium eradication and association with bacterium virulence profiles.
Blood
; 110(12): 3833-41, 2007 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-17652264